References
- Dinarello C. A. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627–1652
- Matsushima K., Akahoshi T., Yamada M., Furutari Y., Oppenheim J. J. Properties of a specific interleukin-1 (IL-1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL-1α and IL-1β. J. Immunol. 1986; 136: 4496–4502
- Bristulf J., Gatti S., Malinowsky D., Sundgren A. K., Bartfai T. IL-1 stimulates the expression of type I and II IL-1 receptors in the rat insulinoma cell line Rinm5F; sequencing a rat type II IL-1 receptor cDNA. Eur. Cytokine Netw. 1994; 5: 319–330
- Dripps D. J., Branduber B. J., Thompson R. C., Eisenberg S. P. IL-1 receptor antagonist binds to the 80 kDa IL-1 receptor but does not initiate signal transduction. J. Biol. Chem. 1991; 266: 10331–10336
- McMahan C. J., Slack J. L., Mosley B., Cosman D., Luton S. D., Brunton L. L., Grubin C. E., Wignall J. M., Jenkino N. A., Brannan C. I., Copeland N. G., Huebner K., Groce C. M., Cannizzarro L. A., Benjamin D., Dower S. K., Springs M. K., Sims J. E. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 1991; 10: 2821–2832
- Eizirik D. L., Tracey D. E., Bendtzen K., Sandler S. An interleukin-1 receptor antagonist protein protects insulin-producing β-cells against suppressive effects of IL-1β. Diabetologia 1991; 34: 445–448
- Deyerle K. L., Sims J. L., Dower S. K., Bothwell M. A. Pattern of IL-1 receptor gene expression suggests role in noninflammatory processes. J. Immunol. 1992; 149: 1657–1662
- Varey A. M., Lydyard P. M., Dean B. M., Van der Meide P. H., Baird J. D., Cooke A. IFN-γ induces class II MHC antigens on RINm5F cells. Diabetes 1988; 37: 209–212
- Chick W. L., Wawer S., Chute R. N., Like A. A., Lauris V., Kitchen K. C. A transplantable insulinoma in the rat. Proc. Natl. Acad. Sci. USA 1977; 74: 628–632
- Gadzar A. F., Chick W. L., Oie H. K. Continuous clonal insulin-and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor. Proc. Natl. Acad. Sci. USA 1980; 77: 3519–3523
- Hunter W. M., Greenwood F. C. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 1962; 194: 495–496
- Dower S. K., Kronheim S. R., Hopp T. P., Cantrell M., Deeley M., Gillis S., Henney C. S., Urdal D. L. The cell surface receptors for IL-1α and IL-1β are identical. Nature 1986; 324: 266–268
- Voyiatzaki C. S., Soteriadou K. P. Evidence of transferrin binding sites on the surface of Leishmania promastigotes. J. Biol. Chem. 1990; 265: 22380–22386
- Vassiliadis S., Guilbert L. J., Kyrpides N., Papamatheakis J. Different molecular mechanisms lead to same endpoints with different function: TNF-α induces non-functional CSF-1 receptors on HL-60 cells in contrast to IFN-γ. J. Receptor Res. 1992; 12: 59–70
- Munson P. G., Rodbard D. LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Analyt. Biochem. 1980; 107: 220–239
- Vassiliadis S., Papadopoulos G. K. IL-6-mediated MHC class II induction on RIN-5AH insulinoma cells by IFN-γ occurs via the G-protein pathway. Med. Inflamm. 1995; 4: 374–379
- Todd J. A., Acha-Orbea H., Bell J. I., Chao N., Fronek Z., Jacob C. O., McDermott M., Sinha A. A., Timmerman L., Steinman L., McDevitt H. O. A molecular basis for MHC class II associated autoimmunity. Science 1988; 240: 1003–1009
- Mitlianga P. G., Germanidis G. S., Moutsopoulos H. M., Papadopoulos G. K. The effect of TGF-β1, and TNF-α on the cytotoxic/cytostatic action of interleukin-1 (α and β isoforms) on the pancreatic β cell line RIN-5AH. Int. J. Immunopathol. Pharmacol. 1995; 8: 67–77
- Palmer J., Helqvist S., Spinas G. A., Molrig J., Mandrup-Poulsen T., Andersen H. U., Nerup J. The beta cell- a moving target? Interaction between pancreatic beta cell activity, IL-1 concentration, and IL-1 exposure on insulin secretion from isolated rat islets of Langerhans. Diabetes 1989; 38: 1211–1216
- Corbert T., Wang J. L., Misko T. P., Zhao W. G., Hickey W. F., McDaniel M. L. Nitric oxide mediates IL-1β-induced islet dysfunction and destruction - Prevention by dexamethasone. Autoimmunity 1993; 15: 145–152
- Linge C., Green M. R. Growth factors-A practical approach, I. McKay, I. Leigh. Oxford University Press, Oxford 1993; 201–236
- Kolb H., Kolb-Bachofen V. Nitric oxide: a pathogenic factor in autoimmunity. Immunol. Today 1992; 13: 157–160